Chromatography And Analysis Flashcards

1
Q

Summary of Phase I Metabolism

A
  • Almost any chemical transformation can be catalyzed by enzyme systems, mainly in the liver
  • These systems developed primarily to process endogenous compounds and dietary xenobiotics
  • Many xenobiotics are substrates for a number of different Phase I reactions, e.g. diazepam
  • Phase I reactions can be used to activate or alter the activity of drugs, but are primarily employed to prepare xenobiotics for Phase II processes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cytochrome P450 Oxidations

A

O-dealkylation

Codeine –> (CYP2D6) Morphine

H3CO –> HO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Summary of Phase II Metabolism

A
  • Reactions are generally with Phase I products
  • Common requirement for an energy rich or “activated” intermediate
  • Products are generally more water soluble and are ready for excretion
  • There are many complementary, sequential and competing pathways
  • Together with phase I metabolism, this is a coupled interactive system interfacing with endogenous metabolic pathways
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Glucuronidation

A

ROH - not excreted in large amounts

UDP-glucuronosyl transferase - not water soluble

Glucuronide conjugate (B) - water soluble, excreted in large quantities

Glucuronide will be hydrolysed by enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

by increasing stationary phase

A

retention can be increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Chromatography

A
  • A technique used to analyse and separate a mixture of compounds into individual components
  • Stationary phase versus mobile phase
  • Traditional view is that separation is achieved by the distribution of molecules between a stationary phase and a mobile phase
  • Many different chromatography experiments
  • Chromatography can be linked with other methods of analysis (hyphenated techniques)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Chromatographies

A
  • Adsorption chromatography, e.g. TLC, column
  • Stationary phase is solid, e.g. silica, alumina
  • Partition chromatography, e.g. HPLC
  • Both stationary and mobile phase are ‘liquids’
  • Ion-exchange chromatography
  • Stationary phase is an ion-exchange resin
  • Gel permeation chromatography
  • Size-exclusion chromatography
  • Affinity chromatography
  • Ligand immobilised on solid, stationary phase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Thin Layer Chromatography (TLC)

A

qualitative technique

Rf of compound 1 = X1/Xs
• Silica stationary phase: non-polar compounds eluted first
• Non-polar versus polar solvents, reverse phase TLC
• Visualisation using UV, iodine, sulfuric acid, molybdate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what phases used mostly in TLC

A

polar mobile phases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

‘Lab-Scale’ Column Chromatography

A
  • qualitative technique
    • Sometimes viewed as a black art
    • Typically the separation of organic compounds on an inert stationary phase, e.g. silica or alumina
    • Column packing method can affect results
    • Gravity columns driven by the solvent head
    • Flash column chromatography is driven by the application of pressure to the solvent head
    • Must do TLC first before starting column and carry out TLC throughout to detect eluted compounds
    • Excellent technique but preparative, not analytical
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Analytical Techniques

A
  • Used for the quantitative analysis of components of a (complex) mixture e.g. a pharmaceutical formulation
  • Analytes are typically separated based on differing affinities for the stationary and mobile phases
  • Mobile phase can be a gas e.g. gas chromatography (GC) or a liquid e.g. high performance liquid chromatography (HPLC)
  • HPLC is widely used in pharmaceutical analysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Retention factor k

A
  • measures how long the material is retained in the column
  • retention factor is affected by the mobile stationary phase
    • Independent of column length or flow rate
    • Need to measure column dead time to - using dead time you can get your retention factor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Separation Factor a

A
  • Identifies when peaks elute relative to one another
  • Ratio of the retention factors (k2 > k1)
  • Separation factor >1 to achieve separation
  • Governed primarily by the stationary phase selection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

a =

A

k2 / k1 = tr,2 - to/ tr,1 - to

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Column Efficiency (Plate Number) N

A

• Represents narrowness of the peak
• Columns with large values of N give narrower peaks
-the narrower the peak, the better the separation
-the larger the number of plates you have, the higher the amount of separation
-the greater the depth of stationary phase , the better the separation
-the more densely the column in HPLC is packed, the greater the efficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is plate number and equation

A

each layer is called a plate

N = 5.54 (tr/w0.5)2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Asymmetry Factor As

A
  • In practice, peak shapes are not gaussian and have ‘tails’

* As 0.9 → 1.2 acceptable; As >1 tailing, As <1 fronting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

When does tailing increase

A

tailing increases when the column becomes worn out, the more tailing you get the more likely the peaks are to overlap

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Resolution R

A
  • Ideal valley between peaks should return to the baseline
  • R is a quantitative measure of separation

R = (square root)N / 4 x k/k + 1 x a-1/a

don’t need to remember the formulae, just understand it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

• To achieve resolution:

A
  • Peaks should be retained on the column (k > 0) - need to have a decent retention time
  • Peaks have to be separated from one another ( > 1) - need a good value of alpha
  • The column must develop some min value of N - the more efficient the column, the greater the resolution. the older the column, the older the mobile phase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Varying Conditions

A

resolution affected by the efficiency of the column and mobile phase

  1. initial
  2. vary k’ - if retention time is increased
  3. increase N - brand new column, more narrow peaks
  4. increase a - combination of a good efficient column and mobile phase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Gas Chromatography (GC)

A
  • turns material into gas
    -used to detect volatile agents but not small molecules
    • Sample is injected on to column (i.d. 0.1–0.5 mm 60 m)
    • The column is heated to release the volatile components
    • The mixture is separated on the column and various methods used to detect each component
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

High Performance Liquid Chromatography (HPLC)

A
  • The sample is injected as a solution on to the column

* The mixture is separated on the column and each of the components is detected using some means

24
Q

HPLC Overview

A
  • A typical apparatus consists of a mobile phase reservoir, high pressure pump, injection valve, sample loop, column and detector
  • Mobile phase flows constantly through the pump, column and detector
  • Injection valve introduces the sample to this flow
25
Q

HPLC Columns

A
  • Stainless steel components, able to withstand high pressures and wide range of solvent systems
  • Commonly 10 cm in length with an internal diameter (ID) of 4.6 mm (can be 5 – 25 cm in length)
  • Stationary phase is packed into the stainless steel column under high pressure
  • Stationary phase commonly consists of silica particles with a diameter of 5 μm but can be as little as 1.7 μm
  • Stationary phase can be modified to allow separation of different molecules e.g. chiral stationary phase used to separate enantiomers
26
Q

Normal vs Reverse Phase HPLC

A
  • Historically the stationary phase consisted of unmodified silica (Si-OH) and was more polar than the mobile phase (normal phase HPLC)
  • In >95% of modern HPLC analysis the silica has been modified to make it less polar (reverse phase HPLC)
  • Typical modifications include the addition of C18 alkyl groups to the silica surface (octadecylsilyl, ODS)
  • The choice of column depends on the analytes to be separated e.g. analytes that are non-polar will be retained for longer on a reverse phase column and vice-versa – RP-HPLC used most frequently
27
Q

Reverse phase HPLC and Log P

A
  • Log P is a measurement of the hydrophobicity of a particular molecule
  • Analyte retention is based on the interaction between the analyte and the mobile and stationary phases
  • Interactions with the mobile phase become important
28
Q

Reverse phase HPLC and higher Log P

A

• The higher the Log P of a molecule the more it interacts with the ODS stationary phase, therefore it’s retention time is increased

29
Q

Reverse phase HPLC and lower Log P

A

• The lower the Log P of a molecule the less it interacts with the ODS stationary phase, therefore it’s retention time is decreased

30
Q

Reverse phase (RP) HPLC and pH - What is the phosphoric acid for?

A

adjusts the pH of the mobile phase

31
Q

RP-HPLC and pH

A

• A significant number of pharmaceutically relevant molecules contain ionisable functional groups
• Poor retention/peak shape is often observed for ionised analytes
• A molecule being analysed should be predominantly in a non-ionised form
• For acids, adjusting the pH of the mobile phase to 1 pH unit below the pKa of the analyte ensures 90 % of the analyte is in the non-ionised form (1 pH unit above the pKa for bases)
-pH affects retention times

32
Q

Material for RP-HPLC

A

material needs to be non-ionised to be analysed by RP-HPLC

33
Q

Effect of pH on the retention of a basic analyte during reverse phase HPLC

A
  • Retention factor is reduced at low pH

* Retention factor is increased at high pH

34
Q

Effect of pH on the retention of an acidic analyte during reverse phase HPLC

A

• Retention factor is reduced at high pH
• Retention factor is increased at low pH
- for acids need to have a low pH

35
Q

Detectors

A

• Range of detectors available for both GC and HPLC

  • Most based upon spectroscopic or colorimetric method
  • Mass spectrometry
  • Flame ionisation
  • UV/vis detector: flow-through cell
  • Diode array detector: flow-through cell
  • Fluorescence detector: flow-through cell
  • Apparatus linked to some other means of analysis
36
Q

HPLC in pharmaceutical analysis

A

-Widely used in all aspects of pharmaceutical dosage form development and manufacture including:
HPLC in pharmaceutical analysis
• Drug discovery
• Pre-formulation
• Impurity testing of API and excipients
• Formulation
• Quality assurance (QA) testing e.g. API content, stability studies, impurities, degradation products
• Pharmacokinetic and drug metabolism studies
• Separation and quantification of chiral API isomers

37
Q

‘Hyphenated’ Techniques

A
  • GC-MS: GC coupled to MS
  • LC-MS: HPLC coupled to MS
  • MS-MS: tandem mass spectrometry
38
Q

LC-MS

A

• The coupling of HPLC with mass spectrometry (MS)
- observes ions, doesn’t detect neutral species
• More difficult than coupling GC to MS since the analyte is already in an inert gaseous phase
• Mobile phase must be removed before MS
• The analyte(s) must be ionised prior to entering the mass spectrometer
• A range of ionisation methods e.g. ESI, EI, APCI
• Used when the identity of the analyte is unknown or it shows poor intensity using other detectors

39
Q

LC-MS diagram

A

Inlet (solid sample chromatography) -> Ion source ( EI, CI, FAB, MALDI, ESI, APCI) -> Mass filter (Magnetic sector, quadrupole, time of flight, ion trap) -> Detector -> Spectrum

  • HPLC flow rate typically 1 mL/min or less
  • Polarity of the ionisation source (+ve or –ve) depending on analyte
  • Detector produces a signal proportional to the number of ions impacting it
40
Q

Applications of LC-MS in Pharmaceutical Analysis

A
  • Mainly used where the analyte(s) are unknown and require identification
  • Drug discovery (characterisation)
  • Drug metabolism studies (in vitro and in vivo)
  • Analysis and identification of impurities e.g. degradation products in pharmaceutical formulations
  • Determination of active/inactive chiral impurities in API e.g. stereoisomers
41
Q

The Mass Spectrometer

A
  • Almost modular, dependent upon intended analyte
  • Sensitive
  • Destructive
  • Requires high vacuum
  • Automated in hyphenated techniques

Inlet (Volatile or Solid Sample,Chromatography effluent) -> Ion Source (Ionisation techniques EI, CI, FAB - MALDI, ESI, APCI) -> Mass Filter (Magnetic Sector Quadrupole (quad) Time Of Flight (TOF) Ion Trap FT-ICR) -> Mass Filter (MS-MS MS-MS-MS) Detector -> analysis

42
Q

Ionisation Techniques

A
  • ‘Hard’ techniques
    • Electron Ionisation (EI) (much fragmentation)
  • ‘Soft’ techniques (more likely to observe molecular ion)
    • Chemical Ionisation (CI) (fragmentation)
    • Fast Atom Bombardment (FAB)
    • Electrospray Ionisation (ESI) (no vacuum)
    • Matrix-Assisted Laser Desorption Ionisation (MALDI)
    • Atmospheric Pressure Chemical Ionisation (APCI)
43
Q

Mass ‘Filtration’/Analysis

A

Time Of Flight (TOF)
• Electrostatic sector + magnetic sector = HRMS
• Quadrupole (Quad)

44
Q

Interpretation: Molecular Ion

A
  • In a clean sample, i.e. one compound, the molecular ion is the radical cation formed from the compound of interest
  • For the majority of techniques it is the highest observable ion but may not be the most intense peak
  • The peak with maximum intensity, i.e. 100%, is termed the base peak and intensities are measured relative to it
  • Possible to estimate molecular formula if no CHN%
  • The Nitrogen Rule
  • Even m/z molecular ion = even number of N (or zero)
  • Odd m/z molecular ion = odd number of N
45
Q

Interpretation: Fragmentation

A
  • Fragmentation is essentially the molecule falling apart/ disintegrating inside the mass spectrometer
    • Ionisation techniques result in more/less fragmentation
    • Collisions between molecular ions and fragment ions
    • Fragmentation and rearrangement can occur
    • Loss of neutral molecules to give stable ions
  • Valuable structural information; fragments and losses
  • Fingerprint: like IR, each molecule has a unique mass spectrum when measured under identical conditions
  • It is not necessary to identify every ion in a spectrum but knowing a few significant patterns and ions is useful
46
Q

Interpretation: Fragmentation

A

One-bond cleavage

Mol• (radical) ecule+ (Even-electron ion, ‘Low’ energy, Few further fragments)

47
Q

Interpretation: Fragmentation

A

Two-bond cleavage

Molec (neutral) ule•+ (Odd-electron ion, Still high energy, Further fragments likely)

48
Q

mass spec only shows

A

mass spec only shows radicals, not neurtal

49
Q

Metabolism of Benzodiazepines

Diazepam

A

Diazepam –> (CYP3A4) Temazepam –> (CYP2C19) R-Oxazepam –> (UGT21A9, UGT2B7) Glucuronidation

Diazepam –> (CYP2C19) Nordazepam –> (CYP3A4) S-Oxazepam –> (UGT2B15) Glucuronidation

50
Q

Metabolism of Benzodiazepines

Alprazolam

A

Alprazolam –> (CY3A5, CY3A4) Hydroxylation –> Glucuronidation

51
Q

Metabolism of Benzodiazepines

Triazolam

A

Triazolam –> (CY3A5, CY3A4) Hydroxylation –> Glucuronidation

52
Q

Metabolism of Benzodiazepines

midazolam

A

midazolam –> (CY3A4) Hydroxylation –> (UGT1A4, UGT2B7, UGT2B4) Glucuronidation

midazolam –> (UGT1A4) Glucuronidation

53
Q

Metabolism of Benzodiazepines

flurazepam

A

flurazepam –> Hydroxylation/Alkylation –> Glucuronidation

54
Q

Metabolism of Benzodiazepines

bromazepam

A

Bromazepam –> (CYP2D6, CYP1A2) –> Hydroxylation –> Glucuronidation

55
Q

Metabolism of Benzodiazepines

lorazepam

A

lorazepam –> (UGT2B15) Glucuronidation

56
Q

Metabolism of Benzodiazepines

clonazepam

A

clonazepam –> (NAT2) Acetylation –> Elimination